Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

This study has been completed.
Information provided by:
EMD Serono Identifier:
First received: April 12, 2006
Last updated: October 22, 2013
Last verified: October 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: July 2003
  Estimated Primary Completion Date: No date given